Mineralys Seeks First-To-Market Edge In Uncontrolled Hypertension

Gloved hand holding a blood pressure meter, indicating high blood pressure
Mineralys shows its aldosterone inhibitor can benefit patients with uncontrolled hypertension • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Therapy Areas